<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id><journal-title-group><journal-title>BMC Cancer</journal-title></journal-title-group><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40405123</article-id><article-id pub-id-type="pmc">PMC12100807</article-id>
<article-id pub-id-type="publisher-id">14330</article-id><article-id pub-id-type="doi">10.1186/s12885-025-14330-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Grading chondroid tumors through MRI radiomics: enchondroma, low-grade chondrosarcoma and higher-grade chondrosarcoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hyerim</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jooyeon</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Seungeun</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Jung</surname><given-names>Joon-Yong</given-names></name><address><email>jy.jung@songeui.ac.kr</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h8jph19</institution-id><institution-id institution-id-type="GRID">grid.412677.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1798 4157</institution-id><institution>Department of Radiology, College of Medicine, </institution><institution>Soonchunhyang University Cheonan Hospital, Soonchunhyang University of Korea, </institution></institution-wrap>Cheonan, Republic of Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03gds6c39</institution-id><institution-id institution-id-type="GRID">grid.267308.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 9206 2401</institution-id><institution>Department of Biostatistics and Data Science, </institution><institution>UTHealth Houston School of Public Health, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01fpnj063</institution-id><institution-id institution-id-type="GRID">grid.411947.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 4224</institution-id><institution>Department of Radiology, Seoul St. Mary&#x02019;s Hospital, College of Medicine, </institution><institution>The Catholic University of Korea, </institution></institution-wrap>222 Banpo-daero, Seocho-gu, Seoul, 06591 Republic of Korea </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>918</elocation-id><history><date date-type="received"><day>13</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">To develop a multiclass radiomics model for differentiating chondroid bone tumors using preoperative MRI.</p></sec><sec><title>Methods</title><p id="Par2">This retrospective study included 120 patients (92 enchondromas, 16 low-grade chondrosarcomas, and 12 intermediate-to-high-grade chondrosarcomas) who underwent contrast-enhanced MRI between 2009 and 2019. Tumor segmentation was manually performed by a musculoskeletal radiologist and validated by a senior radiologist. We used least absolute shrinkage and selection operator (LASSO) and random forest (RF) for feature selection and classification, with and without synthetic minority oversampling technique (SMOTE). Model performance was evaluated using five-fold cross-validation with average precision, accuracy, area under the curve (AUC), and weighted kappa statistics.</p></sec><sec><title>Results</title><p id="Par3">The LASSO&#x02009;+&#x02009;RF model based on all sequences achieved the highest accuracy (0.826&#x02009;&#x000b1;&#x02009;0.065) and AUC (0.967&#x02009;&#x000b1;&#x02009;0.027). The highest mAP (0.750&#x02009;&#x000b1;&#x02009;0.095) was observed in the SMOTE-enhanced T2WI-based model, highlighting the potential impact of class imbalance. Quadratic weighted kappa values ranged from 0.648 to 0.731 across models, indicating substantial agreement with pathological results.</p></sec><sec><title>Conclusions</title><p id="Par4">Preoperative MRI-based radiomics provides a robust method for the classification of chondroid bone tumors, potentially enhancing clinical decision-making.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Radiomics</kwd><kwd>Chondrosarcoma</kwd><kwd>Enchondroma</kwd><kwd>Magnetic resonance imaging</kwd><kwd>Least absolute shrinkage and selection operator.</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>2022R1A2C4002395</award-id><principal-award-recipient><name><surname>Jung</surname><given-names>Joon-Yong</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par5">Cartilaginous bone tumor is composed of chondroid matrix and tumor cells with chondrocyte differentiation [<xref ref-type="bibr" rid="CR1">1</xref>]. The majority of cartilaginous bone tumors are enchondromas, the second most common benign bone tumors [<xref ref-type="bibr" rid="CR2">2</xref>]. Whereas, chondrosarcoma is the third most common primary malignant tumor of the bone and is divided histologically into grade 1, grade 2, and grade 3 chondrosarcoma (CSA) [<xref ref-type="bibr" rid="CR3">3</xref>]. The prediction of grades in cartilaginous bone tumor is of the utmost importance because therapeutic management and prognosis differ according to histologic grade [<xref ref-type="bibr" rid="CR4">4</xref>]. Enchondroma is typically managed to a watch-and-wait approach. Grade 1 CSA generally has a good prognosis with curettage and bone graft, while grade 2 and 3 CSA have a poor prognosis even with wide resection [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. However, differentiation between grade 1 CSA and enchondroma is often difficult due to similarities in imaging and pathological features [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par6">In practice, MRI plays an important role in local staging of chondroid bone tumors, while CT provides complementary information such as matrix mineralization and cortical changes [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Various radiologic features such as endosteal scalloping greater than two-third of cortical thickness, cortical destruction, soft tissue masses, and periosteal reactions are known to suggest CSA over enchondroma [<xref ref-type="bibr" rid="CR8">8</xref>]. However, low-grade CSA often cannot be differentiated from enchondroma based only on imaging features [<xref ref-type="bibr" rid="CR5">5</xref>]. In addition, grade 2 or 3 CSA often mimics low-grade CSA without aggressive imaging features [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Preoperative biopsy is considered to confirm the histologic grades. However, regional biopsy sample could lead to misinterpretation of CSA grade due to the tumor heterogeneity and interobserver discrepancy for overlapping histological features [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par7">Radiomics is a methodology to extract features including texture from images and build a machine-learning model using the features for the task at hands [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>]. Initially, radiomics has applied for oncology field, but today it expands its horizon to inflammatory or degenerative diseases [<xref ref-type="bibr" rid="CR14">14</xref>]. To date, several studies have applied texture analysis or radiomics on CT or MRI of cartilaginous neoplasm [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. Addition of radiomics features to the conventional MRI findings improved the differentiation between enchondroma and CSA [<xref ref-type="bibr" rid="CR18">18</xref>]. Machine-learning model using radiomics features from CT or MRI showed fair diagnostic performance to differentiate low- and higher- grade CSA [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. However, unlike previous studies that primarily focused on binary classification between enchondroma and low-grade CSA, or low-grade and higher-grade CSA, our study is intended to address crucial gap by developing a multiclass radiomics model designed to differentiate across the spectrum of those tumors, thereby aligning more closely with the complexity of clinical decision-making in practice.</p><p id="Par8">Therefore, the purpose of our study is to develop the multiclass radiomics model to differentiate the spectrum of enchondroma, low-grade CSA and intermediate-to-high grade CSA.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Ethics</title><p id="Par9">All procedures performed in this study were conducted in accordance with relevant guidelines and regulations, including the principles outlined in the Declaration of Helsinki. The institutional review board of Seoul St.Mary&#x02019;s Hospital, The Catholic University of Korea approved this retrospective study and waived the need for informed consent.</p></sec><sec id="Sec4"><title>Study design and inclusion/exclusion criteria</title><p id="Par10">We collected the data from January 2009 to August 2019 for research purpose. Patient information was retrieved through electronic medical records from the department of orthopedic surgery and pathology. The authors collected the data and anonymized the patient&#x02019;s information. 158 consecutive patients who received MRI and were clinically or pathologically confirmed enchondroma or CSA were retrospectively included in our study.</p><p id="Par11">The criteria for clinical confirmation of enchondroma were as follows: (1) An intraosseous mass confined to the medullary cavity, (2) Absence of cortical scalloping by the mass in long bones, (3) Presence of internal matrix calcifications with a chondroid pattern, (4) Stability in size, marginal conspicuity, and internal matrix over 2 years on serial plain radiographs. Chondroid tumors meeting all these criteria were presumed to be benign enchondromas without the need for surgical biopsy. Masses that did not fulfill the clinical criteria or displayed aggressive features such as cortical disruption, periosteal reaction, extraosseous soft tissue extension, or internal heterogeneity on initial imaging evaluation were pathologically confirmed via intralesional curettage or resection.</p><p id="Par12">The inclusion criteria were (1) enchondroma or CSA that was pathologically confirmed by incisional biopsy or intralesional curettage, resection, (2) enchondroma that was clinically confirmed based on the aforementioned criteria, (3) MRI scan performed within 3 months in pathologically confirmed cases.</p><p id="Par13">Patients with recurrent tumors, previous incisional biopsy or chemo-radiation before MRI, images with insufficient quality&#x02014;such as those lacking essential sequences or affected by motion artifacts, and small enchondromas less than 1&#x000a0;cm were excluded. A flowchart of the patient selection process is shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.</p><p id="Par14">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Patient Selection Flowchart for Chondroid Bone Tumor Classification</p></caption><graphic xlink:href="12885_2025_14330_Fig1_HTML" id="d33e317"/></fig>
</p></sec><sec id="Sec5"><title>Study cohorts</title><p id="Par15">A total of 120 patients were retrospectively included in the study. Among them, 28 patients had pathologically confirmed chondroid tumors, and 92 patients had clinically diagnosed enchondromas based on the predefined clinical criteria. The mean follow-up period for these patients was 7.2 years.</p><p id="Par16">Among the 120 patients included in the study, the number of patients with enchondroma, CSA grade 1, and grade 2&#x02009;+&#x02009;3 were 92, 16, and 12 respectively. Patient demographics, lesion locations, and grading are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par17">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Patient demographic and location of tumors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left">Enchondroma<break/>(<italic>n</italic>&#x02009;=&#x02009;92)</th><th align="left">Low-grade CSA<break/>(<italic>n</italic>&#x02009;=&#x02009;16)</th><th align="left">Higher-grade CSA (<italic>n</italic>&#x02009;=&#x02009;12)</th></tr></thead><tbody><tr><td align="left" colspan="2">Age</td><td align="left">40 (13.8)</td><td align="left">48(14.6)</td><td align="left">50(15.4)</td></tr><tr><td align="left" colspan="2">Gender (M: F)</td><td align="left">33:59</td><td align="left">6:10</td><td align="left">4:8</td></tr><tr><td align="left" rowspan="8">Location</td><td align="left">Femur</td><td align="left">2</td><td align="left">2</td><td align="left">2</td></tr><tr><td align="left">Tibia</td><td align="left">1</td><td align="left">1</td><td align="left">1</td></tr><tr><td align="left">Foot</td><td align="left">14</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">Pelvis</td><td align="left">0</td><td align="left">2</td><td align="left">4</td></tr><tr><td align="left">Humerus</td><td align="left">8</td><td align="left">10</td><td align="left">1</td></tr><tr><td align="left">Scapula</td><td align="left">0</td><td align="left">1</td><td align="left">2</td></tr><tr><td align="left">Hand</td><td align="left">67</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">Rib</td><td align="left">0</td><td align="left">0</td><td align="left">2</td></tr></tbody></table></table-wrap>
</p><p id="Par18">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>MR parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameters</th><th align="left">Axial T1-WI</th><th align="left">Fat-suppressed axial T2-WI</th><th align="left">Fat suppressed sagittal or coronal T2-WI</th><th align="left">Contrast enhanced fat suppressed, axial T1-WI</th></tr></thead><tbody><tr><td align="left">
<bold>Field of view</bold>
</td><td align="left">100&#x02013;280&#x000a0;mm</td><td align="left">100&#x02013;280&#x000a0;mm</td><td align="left">200&#x02013;350&#x000a0;mm</td><td align="left">100&#x02013;280&#x000a0;mm</td></tr><tr><td align="left">
<bold>Matrix size</bold>
</td><td align="left"><p>384&#x02009;&#x000d7;&#x02009;230</p><p>&#x02013; 512&#x02009;&#x000d7;&#x02009;256</p></td><td align="left"><p>256&#x02009;&#x000d7;&#x02009;128</p><p>&#x02013; 512&#x02009;&#x000d7;&#x02009;256</p></td><td align="left"><p>256&#x02009;&#x000d7;&#x02009;128</p><p>&#x02013; 512&#x02009;&#x000d7;&#x02009;256</p></td><td align="left"><p>384&#x02009;&#x000d7;&#x02009;230</p><p>&#x02013; 512&#x02009;&#x000d7;&#x02009;256</p></td></tr><tr><td align="left">
<bold>TR (msec)/TE (msec)</bold>
</td><td align="left"><p>650&#x02013;750/</p><p>11&#x02013;15</p></td><td align="left"><p>3400&#x02013;4800/</p><p>68&#x02013;81</p></td><td align="left"><p>3400&#x02013;4800/</p><p>72&#x02013;81</p></td><td align="left"><p>700&#x02013;820/</p><p>15&#x02013;18</p></td></tr><tr><td align="left">
<bold>Number of Slices</bold>
</td><td align="left">25&#x02013;40</td><td align="left">25&#x02013;40</td><td align="left">25&#x02013;35</td><td align="left">25&#x02013;40</td></tr><tr><td align="left">
<bold>Slice thickness</bold>
</td><td align="left">3&#x02013;8&#x000a0;mm</td><td align="left">3&#x02013;8&#x000a0;mm</td><td align="left">3&#x02013;5&#x000a0;mm</td><td align="left">3&#x02013;8&#x000a0;mm</td></tr><tr><td align="left">
<bold>Intersection gap</bold>
</td><td align="left">0&#x02013;0.8&#x000a0;mm</td><td align="left">0&#x02013;0.8&#x000a0;mm</td><td align="left">0&#x02013;0.8&#x000a0;mm</td><td align="left">0&#x02013;0.8&#x000a0;mm</td></tr><tr><td align="left">
<bold>Turbo factor </bold>
</td><td align="left">3</td><td align="left">13&#x02013;17</td><td align="left">13&#x02013;18</td><td align="left">3&#x02013;5</td></tr><tr><td align="left">
<bold>Number of excitation</bold>
</td><td align="left">1</td><td align="left">1</td><td align="left">1</td><td align="left">1</td></tr><tr><td align="left">
<bold>Fat suppression</bold>
</td><td align="left">-</td><td align="left">Chemical Shift Selective or Dixon-technique</td><td align="left">Chemical Shift Selective</td><td align="left">Chemical Shift Selective</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec6"><title>MRI data acquisition</title><p id="Par19">MRI examinations were performed using one of two 3.0 T imagers (Verio and Magnetom Vida; Siemens Medical Solutions, Erlangen, Germany) with dedicated surface coils tailored to the tumor location. The standard MRI protocols included longitudinal fat-suppressed T2-weighted turbo spin-echo (TSE) sequence, axial T1-weighted TSE sequence, axial T2-weighted TSE sequences with and without fat suppression, and longitudinal and axial fat-suppressed contrast-enhanced T1-weighted TSE sequences. The MRI parameters for each sequence are detailed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec><sec id="Sec7"><title>Segmentation</title><p id="Par20">Lesion segmentation was performed using the open-source software ITK-SNAP (version 3.9.0, <ext-link ext-link-type="uri" xlink:href="http://www.itksnap.org/">http://www.itksnap.org/</ext-link>) [<xref ref-type="bibr" rid="CR21">21</xref>] (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The volume of interest (VOI) was manually delineated along the entire mass. A musculoskeletal radiologist with 2 years of experience (H.P) performed the initial segmentation by drawing a free-hand region of interest (ROI) along the tumor borders on T2-weighted imaging (T2WI), T1-weighted imaging (T1WI), and contrast-enhanced T1-weighted imaging (CE-T1WI) sequences, excluding any peritumoral abnormalities. The segmentations were subsequently validated by a second musculoskeletal radiologist with 16 years of experience (J.Y.J). Both radiologists were blinded to tumor entity or grade during segmentations.</p><p id="Par21">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Radiomics Pipeline for Chondroid Bone Tumor Classification Using MRI Features</p><p> Preoperative MR images were manually segmented, and radiomic features were extracted after standardization, including first-order, shape, and texture features. Key features were selected using the least absolute shrinkage and selection operator (LASSO) and random forest methods. Multiple classification models were developed using combinations of selected features, and five-fold cross-validation was performed to evaluate model accuracy and robustness in differentiating between enchondroma, low-grade, and higher-grade chondrosarcomas. Statistical analyses, including accuracy, weighted kappa, area under receiver-operating characteristic (ROC) curve, and average precision, were conducted to assess model performance</p></caption><graphic xlink:href="12885_2025_14330_Fig2_HTML" id="d33e659"/></fig>
</p></sec><sec id="Sec8"><title>Image preprocessing and extraction of features</title><p id="Par22">To minimize the intensity variations, image normalization was performed before feature extraction. During the feature extractions, image resampling and gray-level discretion were conducted. Image pre-processing and feature extraction were performed using PyRadiomics (Ver 3.0) [<xref ref-type="bibr" rid="CR22">22</xref>]. Image preprocessing consisted in resampling to a 1&#x02009;&#x000d7;&#x02009;1&#x02009;&#x000d7;&#x02009;1 isotropic voxel (mm<sup>3</sup>), intensity normalization and discretization with a fixed bin width of 25. A detailed description of the implementation of these steps and radiomic features extracted by the software is available in the official documentation (<ext-link ext-link-type="uri" xlink:href="https://pyradiomics.readthedocs.io/en/latest/features">https://pyradiomics.readthedocs.io/en/latest/features</ext-link>. html). Within each VOI, (a) 18 first-order features, (b) 14 shape and size-based features, and (c) 68 texture features were extracted. We only used original features acquired from each sequence.</p></sec><sec id="Sec9"><title>Feature selection methods and classification model Building</title><p id="Par23">We used least absolute shrinkage and selection operator (LASSO) and random forest (RF) for feature selection and the development of our classification model. RF is a well-established classifier in radiomics [<xref ref-type="bibr" rid="CR23">23</xref>]. For the 3-class classification task of RF, the predicted class was determined based on the highest predicted probability among the three classes. While RF includes its own feature selection process, LASSO is widely used due to its ability to minimize overfitting [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. We applied two different schemes for feature selection using LASSO. First, features were selected once from the entire set by LASSO, and the selected features were consistently used to train and validate each model. Second, features were repeatedly selected by LASSO for each training set during 5-fold cross-validation.</p><p id="Par24">To address the issue of class imbalance, we applied the synthetic minority oversampling technique (SMOTE). This method generates synthetic examples to balance the dataset, which is known to improve the accuracy of classifiers for minority classes [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par25">Ultimately, we developed 4 different models: LASSO (single)&#x02009;+&#x02009;RF, SMOTE&#x02009;+&#x02009;LASSO (single)&#x02009;+&#x02009;RF, LASSO (repeated)&#x02009;+&#x02009;RF, SMOTE&#x02009;+&#x02009;LASSO (repeated)&#x02009;+&#x02009;RF using different combination of aforementioned algorithms.</p><p id="Par26">For feature input, we used various input features from T1WI, T2WI, CE-T1WI, and combination of all sequences. Additionally, we constructed an ensemble model using a weighted voting method. This ensemble combined the classification results of three RF models, each trained on features from T1, T2, and CE sequences, respectively. The highest voted group was selected based on the weights assigned to each classifier [<xref ref-type="bibr" rid="CR27">27</xref>]. The overall steps of our radiomics pipeline are illustrated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.</p></sec><sec id="Sec91"><title>Statistical analysis</title><p id="Par27">We assessed model performance using averaged accuracy, average precision (AP) and area under the curve (AUC) from five-fold cross-validation. The classification accuracy was used to evaluate the model&#x02019;s ability to differentiate among the three grades&#x02014;enchondroma, low-grade CSA, and higher-grade CSA. Since AP and AUC are not directly applicable as metrics for three-class classification, it was specifically employed for binary classification between enchondroma and CSA.</p><p id="Par28">To evaluate the agreement between pathological results and the machine learning models, we applied the quadratic weighted kappa coefficient to measure the consistency among the models.</p><p id="Par29">APs were calculated using Python (scikit-learn library, version 1.3.0). All other statistical analyses were performed using R version 4.0.0 (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/)">http://www.r-project.org/)</ext-link>.</p></sec></sec><sec id="Sec1432"><title>Results</title><p id="Par30">All classification models demonstrated overall mean accuracies over 0.8 and mean AP around 0.7. Among the different models, the LASSO (single)&#x02009;+&#x02009;RF model tends to demonstrated the highest accuracy, AUC and mean AP.</p><p id="Par31">In the model combining LASSO (single), SMOTE, and RF, T2WI-derived features provided the highest accuracy, while the combination of all sequences resulted in the highest AUC. Mean AP was the highest for the T2WI feature set using the LASSO (single)&#x02009;+&#x02009;SMOTE&#x02009;+&#x02009;RF model. All classification models showed substantial agreements with pathologic grading, with weighted kappa values above 0.6 (Tables&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>).</p><p id="Par32">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Performance of model with single feature selection</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">Features</th><th align="left">Accuracy (mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left">Kappa coefficient<break/>(mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left">AUC (mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left">mAP<break/>(mean&#x02009;&#x000b1;&#x02009;SD)</th></tr></thead><tbody><tr><td align="left">LASSO (single)&#x02009;+&#x02009;RF</td><td align="left">T1WI</td><td align="left">0.823&#x02009;&#x000b1;&#x02009;0.060</td><td align="left">0.648&#x02009;&#x000b1;&#x02009;0.145</td><td align="left">0.956&#x02009;&#x000b1;&#x02009;0.035</td><td char="&#x000b1;" align="char">0.707&#x02009;&#x000b1;&#x02009;0.094</td></tr><tr><td align="left"/><td align="left">T2WI</td><td align="left">0.817&#x02009;&#x000b1;&#x02009;0.066</td><td align="left">0.687&#x02009;&#x000b1;&#x02009;0.114</td><td align="left">0.961&#x02009;&#x000b1;&#x02009;0.034</td><td char="&#x000b1;" align="char">0.729&#x02009;&#x000b1;&#x02009;0.093</td></tr><tr><td align="left"/><td align="left">CE-FST1WI</td><td align="left">0.807&#x02009;&#x000b1;&#x02009;0.066</td><td align="left">0.677&#x02009;&#x000b1;&#x02009;0.148</td><td align="left">0.958&#x02009;&#x000b1;&#x02009;0.033</td><td char="&#x000b1;" align="char">0.649&#x02009;&#x000b1;&#x02009;0.096</td></tr><tr><td align="left"/><td align="left">All</td><td align="left">0.826&#x02009;&#x000b1;&#x02009;0.065</td><td align="left">0.689&#x02009;&#x000b1;&#x02009;0.147</td><td align="left">0.967&#x02009;&#x000b1;&#x02009;0.027</td><td char="&#x000b1;" align="char">0.707&#x02009;&#x000b1;&#x02009;0.094</td></tr><tr><td align="left"/><td align="left">Ensemble</td><td align="left">0.808&#x02009;&#x000b1;&#x02009;0.061</td><td align="left">0.673&#x02009;&#x000b1;&#x02009;0.139</td><td align="left">0.960&#x02009;&#x000b1;&#x02009;0.032</td><td char="&#x000b1;" align="char">0.706&#x02009;&#x000b1;&#x02009;0.098</td></tr><tr><td align="left">LASSO (single)&#x02009;+&#x02009;SMOTE&#x02009;+&#x02009;RF</td><td align="left">T1WI</td><td align="left">0.820&#x02009;&#x000b1;&#x02009;0.063</td><td align="left">0.686&#x02009;&#x000b1;&#x02009;0.127</td><td align="left">0.949&#x02009;&#x000b1;&#x02009;0.038</td><td char="&#x000b1;" align="char">0.687&#x02009;&#x000b1;&#x02009;0.093</td></tr><tr><td align="left"/><td align="left">T2WI</td><td align="left">0.820&#x02009;&#x000b1;&#x02009;0.078</td><td align="left">0.731&#x02009;&#x000b1;&#x02009;0.126</td><td align="left">0.957&#x02009;&#x000b1;&#x02009;0.038</td><td char="&#x000b1;" align="char">0.750&#x02009;&#x000b1;&#x02009;0.095</td></tr><tr><td align="left"/><td align="left">CE-FST1WI</td><td align="left">0.800&#x02009;&#x000b1;&#x02009;0.060</td><td align="left">0.690&#x02009;&#x000b1;&#x02009;0.127</td><td align="left">0.954&#x02009;&#x000b1;&#x02009;0.037</td><td char="&#x000b1;" align="char">0.690&#x02009;&#x000b1;&#x02009;0.086</td></tr><tr><td align="left"/><td align="left">All</td><td align="left">0.813&#x02009;&#x000b1;&#x02009;0.066</td><td align="left">0.715&#x02009;&#x000b1;&#x02009;0.119</td><td align="left">0.966&#x02009;&#x000b1;&#x02009;0.030</td><td char="&#x000b1;" align="char">0.697&#x02009;&#x000b1;&#x02009;0.092</td></tr><tr><td align="left"/><td align="left">Ensemble</td><td align="left">0.813&#x02009;&#x000b1;&#x02009;0.070</td><td align="left">0.712&#x02009;&#x000b1;&#x02009;0.126</td><td align="left">0.958&#x02009;&#x000b1;&#x02009;0.036</td><td char="&#x000b1;" align="char">0.702&#x02009;&#x000b1;&#x02009;0.096</td></tr></tbody></table></table-wrap>
</p><p id="Par33">
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Performance of model with repeated feature selection</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">Features</th><th align="left">Accuracy (mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left">Kappa coefficient<break/>(mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left">AUC (mean&#x02009;&#x000b1;&#x02009;SD)</th><th align="left">mAP<break/>(mean&#x02009;&#x000b1;&#x02009;SD)</th></tr></thead><tbody><tr><td align="left">LASSO (repeated)&#x02009;+&#x02009;RF</td><td align="left">T1WI</td><td align="left">0.807&#x02009;&#x000b1;&#x02009;0.064</td><td align="left">0.615&#x02009;&#x000b1;&#x02009;0.174</td><td align="left">0.947&#x02009;&#x000b1;&#x02009;0.043</td><td char="&#x000b1;" align="char">0.680&#x02009;&#x000b1;&#x02009;0.093</td></tr><tr><td align="left"/><td align="left">T2WI</td><td align="left">0.820&#x02009;&#x000b1;&#x02009;0.067</td><td align="left">0.677&#x02009;&#x000b1;&#x02009;0.134</td><td align="left">0.956&#x02009;&#x000b1;&#x02009;0.035</td><td char="&#x000b1;" align="char">0.663&#x02009;&#x000b1;&#x02009;0.100</td></tr><tr><td align="left"/><td align="left">CE-FST1WI</td><td align="left">0.801&#x02009;&#x000b1;&#x02009;0.067</td><td align="left">0.647&#x02009;&#x000b1;&#x02009;0.147</td><td align="left">0.950&#x02009;&#x000b1;&#x02009;0.035</td><td char="&#x000b1;" align="char">0.705&#x02009;&#x000b1;&#x02009;0.090</td></tr><tr><td align="left"/><td align="left">All</td><td align="left">0.806&#x02009;&#x000b1;&#x02009;0.056</td><td align="left">0.657&#x02009;&#x000b1;&#x02009;0.130</td><td align="left">0.951&#x02009;&#x000b1;&#x02009;0.034</td><td char="&#x000b1;" align="char">0.687&#x02009;&#x000b1;&#x02009;0.094</td></tr><tr><td align="left"/><td align="left">Ensemble</td><td align="left">0.805&#x02009;&#x000b1;&#x02009;0.061</td><td align="left">0.656&#x02009;&#x000b1;&#x02009;0.146</td><td align="left">0.961&#x02009;&#x000b1;&#x02009;0.029</td><td char="&#x000b1;" align="char">0.705&#x02009;&#x000b1;&#x02009;0.097</td></tr><tr><td align="left">LASSO (repeated)&#x02009;+&#x02009;SMOTE&#x02009;+&#x02009;RF</td><td align="left">T1WI</td><td align="left">0.801&#x02009;&#x000b1;&#x02009;0.076</td><td align="left">0.655&#x02009;&#x000b1;&#x02009;0.176</td><td align="left">0.946&#x02009;&#x000b1;&#x02009;0.042</td><td char="&#x000b1;" align="char">0.652&#x02009;&#x000b1;&#x02009;0.093</td></tr><tr><td align="left"/><td align="left">T2WI</td><td align="left">0.815&#x02009;&#x000b1;&#x02009;0.065</td><td align="left">0.674&#x02009;&#x000b1;&#x02009;0.152</td><td align="left">0.949&#x02009;&#x000b1;&#x02009;0.037</td><td char="&#x000b1;" align="char">0.663&#x02009;&#x000b1;&#x02009;0.100</td></tr><tr><td align="left"/><td align="left">CE-FST1WI</td><td align="left">0.802&#x02009;&#x000b1;&#x02009;0.072</td><td align="left">0.691&#x02009;&#x000b1;&#x02009;0.105</td><td align="left">0.946&#x02009;&#x000b1;&#x02009;0.038</td><td char="&#x000b1;" align="char">0.705&#x02009;&#x000b1;&#x02009;0.090</td></tr><tr><td align="left"/><td align="left">All</td><td align="left">0.806&#x02009;&#x000b1;&#x02009;0.062</td><td align="left">0.681&#x02009;&#x000b1;&#x02009;0.121</td><td align="left">0.952&#x02009;&#x000b1;&#x02009;0.036</td><td char="&#x000b1;" align="char">0.687&#x02009;&#x000b1;&#x02009;0.094</td></tr><tr><td align="left"/><td align="left">Ensemble</td><td align="left">0.806&#x02009;&#x000b1;&#x02009;0.071</td><td align="left">0.689&#x02009;&#x000b1;&#x02009;0.126</td><td align="left">0.951&#x02009;&#x000b1;&#x02009;0.040</td><td char="&#x000b1;" align="char">0.675&#x02009;&#x000b1;&#x02009;0.099</td></tr></tbody></table></table-wrap>
</p><p id="Par34">Application of SMOTE generally did not lead to a substantial improvement in model performance. While slight increases in kappa coefficient and mean AP were observed in some combinations, overall accuracy and AUC values were not consistently enhanced.</p><p id="Par35">In the second approach, where LASSO feature selection was applied at every iteration of the training set and validated in the test set. Compared with single application of LASSO, models using repeated LASSO generally demonstrated slightly decreased performance across all metrics. This trend was consistently observed regardless of the imaging feature sets or ensemble.</p></sec><sec id="Sec911"><title>Discussion</title><p id="Par36">The main finding of our study is that the preoperative MRI based-radiomics model can effectively discriminate among different grades of cartilaginous neoplasm. Overall, performances across the various models were similar with highest accuracy and AUCs of LASSO (single)&#x02009;+&#x02009;RF from all sequences and LASSO, and highest mean AP of LASSO (single)&#x02009;+&#x02009;SMOTE&#x02009;+&#x02009;RF from T2WI.</p><p id="Par37">The SMOTE algorithm was employed to address the class imbalance in our dataset by generating synthetic samples of the minority class [<xref ref-type="bibr" rid="CR26">26</xref>]. Despite the theoretical advantage of balancing the training data, SMOTE did not consistently improve model performance in our study. A slight improvement in AP, which is considered a more appropriate performance metric for imbalanced datasets, was observed in some feature sets, particularly in T2WI-based models, suggesting that class imbalance may have had a greater impact in certain imaging method. However, the lack of consistent benefit across all models indicates that factors beyond simple class imbalance, such as feature quality and sample size, may play a more critical role in determining model performance. The repeated application of LASSO for feature selection during each fold of cross-validation was intended to minimize overfitting and enhance the generalizability of the models [<xref ref-type="bibr" rid="CR28">28</xref>]. However, our results showed that repeated LASSO slightly degraded the model performance compared to a single application of LASSO. This may be due to the increased variability in feature selection across folds, leading to instability in model training.</p><p id="Par38">Differentiating low-grade CSA from enchondroma remains a significant challenge, even for experienced radiologists and pathologists, due to the similarities in imaging and pathological features [<xref ref-type="bibr" rid="CR4">4</xref>]. Accurate diagnosis is essential for determining the appropriate treatment options, which vary based on tumor grades [<xref ref-type="bibr" rid="CR29">29</xref>]. While biopsy is a standard preoperative diagnostic tool, it is susceptible to sampling errors and may result in an underestimation of the diagnosis [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par39">MRI has been widely used to evaluate cartilaginous neoplasm. However, previous studies have shown a variable range of inter-reader agreement for radiologic features [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In light of this, there is a growing need for objective biomarkers that can enhance diagnostic accuracy. Radiomics, which involves the extraction of features from predefined formulas, texture analysis, and original or filtered images, holds promise for providing objective information independent of reader interpretation. However, the performance of radiomics models is heavily influenced by choices in preprocessing, feature selection, and classification [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Previous studies have not fully explored variable methodological options to address data imbalance or improve model performance.</p><p id="Par40">Human readers primarily rely on T2WI and contrast-enhanced sequence for interpretation of tumors, and do less on T1WI when interpreting cartilaginous tumors, focusing instead on its utility for detecting hemorrhage, fat content, or the intensity of edema. However, our study found that T1WI-based radiomics model, despite being underutilized by radiologists in this context, also provided fair performances. Previous studies also have similarly highlighted the importance of T1WI-derived texture features, particularly in differentiating enchondroma from low-grade CSA. Lisson et al. used texture analysis to discriminate low grade CSA from enchondroma and demonstrated that texture features from T1WI sequences were the most important features compared to those from T2WI. Texture features extracted from T2WI sequences showed no statistically difference between low grade CSA group and enchondroma group [<xref ref-type="bibr" rid="CR33">33</xref>]. The authors reported that kurtosis in contrast-enhanced T1WI had the greatest power of differentiation, with 86% accuracy. Our result also showed that kurtosis was also selected from enhanced sequence. Fritz et al. graded cartilaginous bone tumors using 19 texture parameters [<xref ref-type="bibr" rid="CR30">30</xref>]. The authors also reported that texture features extracted from T1WI sequence achieved high sensitivity and specificity for the differentiation of enchondroma and CSA. These findings suggest that T1WI holds substantial value in radiomics, offering insights that are not readily apparent to the naked eye.</p><p id="Par41">Radiomics has been increasingly applied to the study of chondroid tumors, regardless of imaging modality. Previous studies have demonstrated the effectiveness of radiomics in differentiating between various grades of cartilaginous tumors, with models built on CT or MRI features showing varying degrees of success. Gitto et al. developed a machine learning classifier for differentiation atypical cartilaginous tumors and higher-grade CSA of long bones based on preoperative CT radiomic features. This study showed good accuracy in external test cohort and there was no statistical difference compared to accuracy of experienced radiologists [<xref ref-type="bibr" rid="CR19">19</xref>]. Deng et al. reported that the CT texture analysis feature model could well differentiate cartilaginous tumors and could be the best model to differentiate between low- grade and higher-grade CSA. However, they reported that models with T1 and T2WI sequences derived features could not effectively differentiate low-grade from higher-grade CSA [<xref ref-type="bibr" rid="CR12">12</xref>]. Our study contrasts with these works, particularly in the application of different methodological approaches like SMOTE and ensemble techniques. While past studies have shown mixed results depending on the modality and specific features used, our findings highlight the robustness of MRI-based radiomics, regardless of different sequence combinations and model structures.</p><p id="Par42">Several limitations of our study need to be addressed. Firstly, this was a retrospective study, which may introduce biases inherent to such designs. Secondly, our study lacked an external validation cohort, which limits the generalizability of our findings. Thirdly, there was a notable class imbalance among the 3 groups, with significantly fewer CSA cases compared to enchondromas. Although we employed the SMOTE technique to address this issue, this cannot fully replicate the actual data distribution. Therefore, the potential impact of class imbalance on model generalizability cannot be completely addressed. Fourthly, we did not implement automatic segmentation techniques, which may limit the applicability of our model in routine clinical settings. Although manual segmentation allowed for precise delineation of tumor margins and exclusion of peritumoral edema, this approach is labor-intensive, time-consuming and prone to interobserver variability. Finally, diffusion-weighted imaging (DWI) was excluded from this study due to inconsistent availability and the presence of noise in some patients, despite previous reports suggesting limited utility of DWI in differentiating low-grade from high-grade CSA [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec1876"><title>Conclusions</title><p id="Par43">In summary, we developed and assessed radiomics models for the 3-tier classification of cartilaginous bone tumors using preoperative MRI features and various methodological strategies. Across all model consistently showed fair to good performances, especially in models that utilized LASSO for feature selection and RF for classification.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not Applicable</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization: J.Jung Data Collection: H, Park and S. Lee Data Curation: J. Lee Methodology development: J. Lee, S. Lee, J. Jung Manuscript writing: H. Park, J. Jung Supervision: J Jung.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2022R1A2C4002395).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The primary datasets are not publicly available due to data privacy regulations. However, processed secondary data may be available from the corresponding author upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar111"><title>Ethics approval and consent to participate</title><p id="Par44">All procedures performed in this study were conducted in accordance with relevant guidelines and regulations, including the principles outlined in the Declaration of Helsinki. The institutional review board of Seoul St.Mary&#x02019;s Hospital, The Catholic University of Korea approved this retrospective study and waived the need for informed consent.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par45">The authors declare no competing interests.</p></notes><notes id="FPar11"><title>Consent for publication</title><p id="Par46">Not Applicable.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>AP</term><def><p id="Par47">Average Precision</p></def></def-item><def-item><term>AUC</term><def><p id="Par48">Area under the curveCSA Chondrosarcoma</p></def></def-item><def-item><term>DWI</term><def><p id="Par49">Diffusion-weighted imaging</p></def></def-item><def-item><term>LASSO</term><def><p id="Par50">Least absolute shrinkage and selection operator</p></def></def-item><def-item><term>RF</term><def><p id="Par51">Random forest</p></def></def-item><def-item><term>ROI</term><def><p id="Par52">Region of interest</p></def></def-item><def-item><term>SMOTE</term><def><p id="Par53">Synthetic minority oversampling technique</p></def></def-item><def-item><term>TSE</term><def><p id="Par54">Turbo spin echo</p></def></def-item><def-item><term>VOI</term><def><p id="Par55">Volume of interest</p></def></def-item><def-item><term>WI</term><def><p id="Par56">Weighted imaging</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Vickie Y, Jo CDMF. (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. 46: 95&#x02013;104.</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Stomp</surname><given-names>W</given-names></name><name><surname>Reijnierse</surname><given-names>M</given-names></name><name><surname>Kloppenburg</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence of cartilaginous tumours as an incidental finding on MRI of the knee</article-title><source>Eur Radiol</source><year>2015</year><volume>25</volume><fpage>3480</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00330-015-3764-6</pub-id><pub-id pub-id-type="pmid">25994192</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Stomp W, Reijnierse M, Kloppenburg M, et al. Prevalence of cartilaginous tumours as an incidental finding on MRI of the knee. Eur Radiol. 2015;25:3480&#x02013;7.<pub-id pub-id-type="pmid">25994192</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Murphey</surname><given-names>MD</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><name><surname>Wilson</surname><given-names>AJ</given-names></name><name><surname>Kransdorf</surname><given-names>MJ</given-names></name><name><surname>Temple</surname><given-names>HT</given-names></name><name><surname>Gannon</surname><given-names>FH</given-names></name></person-group><article-title>From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation</article-title><source>Radiographics</source><year>2003</year><volume>23</volume><fpage>1245</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1148/rg.235035134</pub-id><pub-id pub-id-type="pmid">12975513</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics. 2003;23:1245&#x02013;78.<pub-id pub-id-type="pmid">12975513</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Le</surname><given-names>H</given-names></name><etal/></person-group><article-title>Radiomics nomograms based on Non-enhanced MRI and clinical risk factors for the differentiation of chondrosarcoma from enchondroma</article-title><source>J Magn Reson Imaging</source><year>2021</year><volume>54</volume><fpage>1314</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1002/jmri.27690</pub-id><pub-id pub-id-type="pmid">33949727</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Pan J, Zhang K, Le H, et al. Radiomics nomograms based on Non-enhanced MRI and clinical risk factors for the differentiation of chondrosarcoma from enchondroma. J Magn Reson Imaging. 2021;54:1314&#x02013;23.<pub-id pub-id-type="pmid">33949727</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Crim</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Layfield</surname><given-names>L</given-names></name><name><surname>Hanrahan</surname><given-names>C</given-names></name><name><surname>Manaster</surname><given-names>BJ</given-names></name></person-group><article-title>Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma?</article-title><source>Eur J Radiol</source><year>2015</year><volume>84</volume><fpage>2222</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.ejrad.2015.06.033</pub-id><pub-id pub-id-type="pmid">26220916</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Crim J, Schmidt R, Layfield L, Hanrahan C, Manaster BJ. Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma? Eur J Radiol. 2015;84:2222&#x02013;30.<pub-id pub-id-type="pmid">26220916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Casali</surname><given-names>PG</given-names></name><name><surname>Bielack</surname><given-names>S</given-names></name><name><surname>Abecassis</surname><given-names>N</given-names></name><etal/></person-group><article-title>Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up</article-title><source>Ann Oncol</source><year>2018</year><volume>29</volume><fpage>iv79</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdy310</pub-id><pub-id pub-id-type="pmid">30285218</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv79&#x02013;95.<pub-id pub-id-type="pmid">30285218</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Douis</surname><given-names>H</given-names></name><name><surname>Singh</surname><given-names>L</given-names></name><name><surname>Saifuddin</surname><given-names>A</given-names></name></person-group><article-title>MRI differentiation of low-grade from high-grade appendicular chondrosarcoma</article-title><source>Eur Radiol</source><year>2014</year><volume>24</volume><fpage>232</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s00330-013-3003-y</pub-id><pub-id pub-id-type="pmid">24337911</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Douis H, Singh L, Saifuddin A. MRI differentiation of low-grade from high-grade appendicular chondrosarcoma. Eur Radiol. 2014;24:232&#x02013;40.<pub-id pub-id-type="pmid">24337911</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Murphey</surname><given-names>MD</given-names></name><name><surname>Flemming</surname><given-names>DJ</given-names></name><name><surname>Boyea</surname><given-names>SR</given-names></name><name><surname>Bojescul</surname><given-names>JA</given-names></name><name><surname>Sweet</surname><given-names>DE</given-names></name><name><surname>Temple</surname><given-names>HT</given-names></name></person-group><article-title>Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features</article-title><source>Radiographics</source><year>1998</year><volume>18</volume><fpage>1213</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1148/radiographics.18.5.9747616</pub-id><pub-id pub-id-type="pmid">9747616</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18:1213&#x02013;37. quiz 1244&#x02013;&#x02009;1215.<pub-id pub-id-type="pmid">9747616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><collab>Skeletal Lesions Interobserver Correlation among Expert Diagnosticians Study G</collab></person-group><article-title>Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones</article-title><source>J Bone Joint Surg Am</source><year>2007</year><volume>89</volume><fpage>2113</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.2106/00004623-200710000-00003</pub-id><pub-id pub-id-type="pmid">17908885</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Skeletal Lesions Interobserver Correlation among Expert Diagnosticians Study G. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007;89:2113&#x02013;23.<pub-id pub-id-type="pmid">17908885</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Deckers</surname><given-names>C</given-names></name><name><surname>Steyvers</surname><given-names>MJ</given-names></name><name><surname>Hannink</surname><given-names>G</given-names></name><name><surname>Schreuder</surname><given-names>HWB</given-names></name><name><surname>de Rooy</surname><given-names>JWJ</given-names></name><name><surname>Van Der Geest</surname><given-names>ICM</given-names></name></person-group><article-title>Can MRI differentiate between atypical cartilaginous tumors and high-grade chondrosarcoma? A systematic review</article-title><source>Acta Orthop</source><year>2020</year><volume>91</volume><fpage>471</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1080/17453674.2020.1763717</pub-id><pub-id pub-id-type="pmid">32429792</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Deckers C, Steyvers MJ, Hannink G, Schreuder HWB, de Rooy JWJ, Van Der Geest ICM. Can MRI differentiate between atypical cartilaginous tumors and high-grade chondrosarcoma? A systematic review. Acta Orthop. 2020;91:471&#x02013;8.<pub-id pub-id-type="pmid">32429792</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Hodel</surname><given-names>S</given-names></name><name><surname>Laux</surname><given-names>C</given-names></name><name><surname>Farei-Campagna</surname><given-names>J</given-names></name><name><surname>Gotschi</surname><given-names>T</given-names></name><name><surname>Bode-Lesniewska</surname><given-names>B</given-names></name><name><surname>Muller</surname><given-names>DA</given-names></name></person-group><article-title>The impact of biopsy sampling errors and the quality of surgical margins on local recurrence and survival in chondrosarcoma</article-title><source>Cancer Manag Res</source><year>2018</year><volume>10</volume><fpage>3765</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.2147/CMAR.S178768</pub-id><pub-id pub-id-type="pmid">30288107</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Hodel S, Laux C, Farei-Campagna J, Gotschi T, Bode-Lesniewska B, Muller DA. The impact of biopsy sampling errors and the quality of surgical margins on local recurrence and survival in chondrosarcoma. Cancer Manag Res. 2018;10:3765&#x02013;71.<pub-id pub-id-type="pmid">30288107</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>XY</given-names></name><name><surname>Chen</surname><given-names>HY</given-names></name><name><surname>Yu</surname><given-names>JN</given-names></name><etal/></person-group><article-title>Diagnostic value of CT- and MRI-Based texture analysis and imaging findings for grading cartilaginous tumors in long bones</article-title><source>Front Oncol</source><year>2021</year><volume>11</volume><fpage>700204</fpage><pub-id pub-id-type="doi">10.3389/fonc.2021.700204</pub-id><pub-id pub-id-type="pmid">34722248</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Deng XY, Chen HY, Yu JN, et al. Diagnostic value of CT- and MRI-Based texture analysis and imaging findings for grading cartilaginous tumors in long bones. Front Oncol. 2021;11:700204.<pub-id pub-id-type="pmid">34722248</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Eefting</surname><given-names>D</given-names></name><name><surname>Schrage</surname><given-names>YM</given-names></name><name><surname>Geirnaerdt</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors</article-title><source>Am J Surg Pathol</source><year>2009</year><volume>33</volume><fpage>50</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/PAS.0b013e31817eec2b</pub-id><pub-id pub-id-type="pmid">18852676</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Eefting D, Schrage YM, Geirnaerdt MJ, et al. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol. 2009;33:50&#x02013;7.<pub-id pub-id-type="pmid">18852676</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>GGillies</surname><given-names>R</given-names></name><name><surname>Kinahan</surname><given-names>P</given-names></name><name><surname>Hricak</surname><given-names>H</given-names></name></person-group><article-title>Radiomics: images are more than pictures</article-title><source>They Are Data Radiol</source><year>2016</year><volume>278</volume><fpage>563</fpage><lpage>77</lpage></element-citation><mixed-citation id="mc-CR14" publication-type="journal">GGillies R, Kinahan P, Hricak H. Radiomics: images are more than pictures. They Are Data Radiol. 2016;278:563&#x02013;77.</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Cuocolo</surname><given-names>R</given-names></name><name><surname>Caruso</surname><given-names>M</given-names></name><name><surname>Perillo</surname><given-names>T</given-names></name><name><surname>Ugga</surname><given-names>L</given-names></name><name><surname>Petretta</surname><given-names>M</given-names></name></person-group><article-title>Machine learning in oncology: a clinical appraisal</article-title><source>Cancer Lett</source><year>2020</year><volume>481</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2020.03.032</pub-id><pub-id pub-id-type="pmid">32251707</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Cuocolo R, Caruso M, Perillo T, Ugga L, Petretta M. Machine learning in oncology: a clinical appraisal. Cancer Lett. 2020;481:55&#x02013;62.<pub-id pub-id-type="pmid">32251707</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Gitto</surname><given-names>S</given-names></name><name><surname>Cuocolo</surname><given-names>R</given-names></name><name><surname>Albano</surname><given-names>D</given-names></name><etal/></person-group><article-title>CT and MRI radiomics of bone and soft-tissue sarcomas: a systematic review of reproducibility and validation strategies</article-title><source>Insights Imaging</source><year>2021</year><volume>12</volume><fpage>68</fpage><pub-id pub-id-type="doi">10.1186/s13244-021-01008-3</pub-id><pub-id pub-id-type="pmid">34076740</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Gitto S, Cuocolo R, Albano D, et al. CT and MRI radiomics of bone and soft-tissue sarcomas: a systematic review of reproducibility and validation strategies. Insights Imaging. 2021;12:68.<pub-id pub-id-type="pmid">34076740</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Gitto</surname><given-names>S</given-names></name><name><surname>Cuocolo</surname><given-names>R</given-names></name><name><surname>Albano</surname><given-names>D</given-names></name><etal/></person-group><article-title>MRI radiomics-based machine-learning classification of bone chondrosarcoma</article-title><source>Eur J Radiol</source><year>2020</year><volume>128</volume><fpage>109043</fpage><pub-id pub-id-type="doi">10.1016/j.ejrad.2020.109043</pub-id><pub-id pub-id-type="pmid">32438261</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gitto S, Cuocolo R, Albano D, et al. MRI radiomics-based machine-learning classification of bone chondrosarcoma. Eur J Radiol. 2020;128:109043.<pub-id pub-id-type="pmid">32438261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>B</given-names></name><name><surname>Muller</surname><given-names>DA</given-names></name><name><surname>Sutter</surname><given-names>R</given-names></name><etal/></person-group><article-title>Magnetic resonance Imaging-Based grading of cartilaginous bone tumors: added value of quantitative texture analysis</article-title><source>Invest Radiol</source><year>2018</year><volume>53</volume><fpage>663</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1097/RLI.0000000000000486</pub-id><pub-id pub-id-type="pmid">29863601</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Fritz B, Muller DA, Sutter R, et al. Magnetic resonance Imaging-Based grading of cartilaginous bone tumors: added value of quantitative texture analysis. Invest Radiol. 2018;53:663&#x02013;72.<pub-id pub-id-type="pmid">29863601</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Gitto</surname><given-names>S</given-names></name><name><surname>Cuocolo</surname><given-names>R</given-names></name><name><surname>Annovazzi</surname><given-names>A</given-names></name><etal/></person-group><article-title>CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas</article-title><source>EBioMedicine</source><year>2021</year><volume>68</volume><fpage>103407</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2021.103407</pub-id><pub-id pub-id-type="pmid">34051442</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Gitto S, Cuocolo R, Annovazzi A, et al. CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas. EBioMedicine. 2021;68:103407.<pub-id pub-id-type="pmid">34051442</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Gitto</surname><given-names>S</given-names></name><name><surname>Cuocolo</surname><given-names>R</given-names></name><name><surname>van Langevelde</surname><given-names>K</given-names></name><etal/></person-group><article-title>MRI radiomics-based machine learning classification of atypical cartilaginous tumour and grade II chondrosarcoma of long bones</article-title><source>EBioMedicine</source><year>2022</year><volume>75</volume><fpage>103757</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2021.103757</pub-id><pub-id pub-id-type="pmid">34933178</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Gitto S, Cuocolo R, van Langevelde K, et al. MRI radiomics-based machine learning classification of atypical cartilaginous tumour and grade II chondrosarcoma of long bones. EBioMedicine. 2022;75:103757.<pub-id pub-id-type="pmid">34933178</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Yushkevich</surname><given-names>PA</given-names></name><name><surname>Piven</surname><given-names>J</given-names></name><name><surname>Hazlett</surname><given-names>HC</given-names></name><etal/></person-group><article-title>User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability</article-title><source>NeuroImage</source><year>2006</year><volume>31</volume><fpage>1116</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.01.015</pub-id><pub-id pub-id-type="pmid">16545965</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage. 2006;31:1116&#x02013;28.<pub-id pub-id-type="pmid">16545965</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>van Griethuysen</surname><given-names>JJM</given-names></name><name><surname>Fedorov</surname><given-names>A</given-names></name><name><surname>Parmar</surname><given-names>C</given-names></name><etal/></person-group><article-title>Computational radiomics system to Decode the radiographic phenotype</article-title><source>Cancer Res</source><year>2017</year><volume>77</volume><fpage>e104</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0339</pub-id><pub-id pub-id-type="pmid">29092951</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to Decode the radiographic phenotype. Cancer Res. 2017;77:e104&#x02013;7.<pub-id pub-id-type="pmid">29092951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Delgado</surname><given-names>M</given-names></name><name><surname>Cernadas</surname><given-names>E</given-names></name><name><surname>Barro</surname><given-names>S</given-names></name><name><surname>Amorim</surname><given-names>D</given-names></name></person-group><article-title>Do we need hundreds of classifiers to solve real world classification problems?</article-title><source>J Mach Learn Res</source><year>2014</year><volume>15</volume><fpage>3133</fpage><lpage>81</lpage></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Fern&#x000e1;ndez-Delgado M, Cernadas E, Barro S, Amorim D. Do we need hundreds of classifiers to solve real world classification problems? J Mach Learn Res. 2014;15:3133&#x02013;81.</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name></person-group><article-title>Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>3001</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti422</pub-id><pub-id pub-id-type="pmid">15814556</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Gui J, Li H. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data. Bioinformatics. 2005;21:3001&#x02013;8.<pub-id pub-id-type="pmid">15814556</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Asl</surname><given-names>BM</given-names></name><name><surname>Setarehdan</surname><given-names>SK</given-names></name><name><surname>Mohebbi</surname><given-names>M</given-names></name></person-group><article-title>Support vector machine-based arrhythmia classification using reduced features of heart rate variability signal</article-title><source>Artif Intell Med</source><year>2008</year><volume>44</volume><fpage>51</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.artmed.2008.04.007</pub-id><pub-id pub-id-type="pmid">18585905</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Asl BM, Setarehdan SK, Mohebbi M. Support vector machine-based arrhythmia classification using reduced features of heart rate variability signal. Artif Intell Med. 2008;44:51&#x02013;64.<pub-id pub-id-type="pmid">18585905</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>B</given-names></name><name><surname>Chawla</surname><given-names>NV</given-names></name><name><surname>Bowyer</surname><given-names>KW</given-names></name><name><surname>Hall</surname><given-names>LO</given-names></name><name><surname>Kegelmeyer</surname><given-names>WP</given-names></name></person-group><article-title>SMOTE: synthetic minority over-sampling technique</article-title><source>J Artif Intell Res</source><year>2002</year><volume>16</volume><fpage>321</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1613/jair.953</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Chawla B, Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321&#x02013;57.</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Osamor</surname><given-names>VC</given-names></name><name><surname>Okezie</surname><given-names>AF</given-names></name></person-group><article-title>Enhancing the weighted voting ensemble algorithm for tuberculosis predictive diagnosis</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41598-021-94347-6</pub-id><pub-id pub-id-type="pmid">33414495</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Osamor VC, Okezie AF. Enhancing the weighted voting ensemble algorithm for tuberculosis predictive diagnosis. Sci Rep. 2021;11:1&#x02013;11.<pub-id pub-id-type="pmid">33414495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Demircio&#x0011f;lu</surname><given-names>A</given-names></name></person-group><article-title>Measuring the bias of incorrect application of feature selection when using cross-validation in radiomics</article-title><source>Insights into Imaging</source><year>2021</year><volume>12</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s13244-021-01115-1</pub-id><pub-id pub-id-type="pmid">33398669</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Demircio&#x0011f;lu A. Measuring the bias of incorrect application of feature selection when using cross-validation in radiomics. Insights into Imaging. 2021;12:1&#x02013;10.<pub-id pub-id-type="pmid">33398669</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>van Praag</surname><given-names>VM</given-names></name><name><surname>Rueten-Budde</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>V</given-names></name><etal/></person-group><article-title>Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas</article-title><source>Surg Oncol</source><year>2018</year><volume>27</volume><fpage>402</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.suronc.2018.05.009</pub-id><pub-id pub-id-type="pmid">30217294</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">van Praag VM, Rueten-Budde A, Ho V, et al. Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas. Surg Oncol. 2018;27:402&#x02013;8.<pub-id pub-id-type="pmid">30217294</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>B</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>DA</given-names></name><name><surname>Sutter</surname><given-names>R</given-names></name><etal/></person-group><article-title>Magnetic resonance imaging&#x02013;based grading of cartilaginous bone tumors: added value of quantitative texture analysis</article-title><source>Invest Radiol</source><year>2018</year><volume>53</volume><fpage>663</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1097/RLI.0000000000000486</pub-id><pub-id pub-id-type="pmid">29863601</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Fritz B, M&#x000fc;ller DA, Sutter R, et al. Magnetic resonance imaging&#x02013;based grading of cartilaginous bone tumors: added value of quantitative texture analysis. Invest Radiol. 2018;53:663&#x02013;72.<pub-id pub-id-type="pmid">29863601</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Parmar</surname><given-names>C</given-names></name><name><surname>Grossmann</surname><given-names>P</given-names></name><name><surname>Bussink</surname><given-names>J</given-names></name><name><surname>Lambin</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>HJ</given-names></name></person-group><article-title>Machine learning methods for quantitative radiomic biomarkers</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/srep13087</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJ. Machine learning methods for quantitative radiomic biomarkers. Sci Rep. 2015;5:1&#x02013;11.</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Hao</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Radiomics and machine learning with multiparametric preoperative MRI May accurately predict the histopathological grades of soft tissue sarcomas</article-title><source>J Magn Reson Imaging</source><year>2020</year><volume>51</volume><fpage>791</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/jmri.26901</pub-id><pub-id pub-id-type="pmid">31486565</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Wang H, Chen H, Duan S, Hao D, Liu J. Radiomics and machine learning with multiparametric preoperative MRI May accurately predict the histopathological grades of soft tissue sarcomas. J Magn Reson Imaging. 2020;51:791&#x02013;7.<pub-id pub-id-type="pmid">31486565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Lisson</surname><given-names>CS</given-names></name><name><surname>Lisson</surname><given-names>CG</given-names></name><name><surname>Flosdorf</surname><given-names>K</given-names></name><etal/></person-group><article-title>Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study</article-title><source>Eur Radiol</source><year>2018</year><volume>28</volume><fpage>468</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s00330-017-5014-6</pub-id><pub-id pub-id-type="pmid">28884356</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Lisson CS, Lisson CG, Flosdorf K, et al. Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study. Eur Radiol. 2018;28:468&#x02013;77.<pub-id pub-id-type="pmid">28884356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Douis</surname><given-names>H</given-names></name><name><surname>Jeys</surname><given-names>L</given-names></name><name><surname>Grimer</surname><given-names>R</given-names></name><name><surname>Vaiyapuri</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>A</given-names></name></person-group><article-title>Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors?</article-title><source>Skeletal Radiol</source><year>2015</year><volume>44</volume><fpage>963</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00256-015-2123-7</pub-id><pub-id pub-id-type="pmid">25744812</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Douis H, Jeys L, Grimer R, Vaiyapuri S, Davies A. Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors? Skeletal Radiol. 2015;44:963&#x02013;9.<pub-id pub-id-type="pmid">25744812</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>